{
    "Title": "Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel Leads",
    "URL": "https://doi.org/10.1371/journal.pntd.0001017",
    "Published": "April 5, 2011",
    "Subject_Areas": [
        "Drug discovery",
        "African trypanosomiasis",
        "Drug research and development",
        "Drug screening",
        "Parasitic diseases",
        "Enzyme inhibitors",
        "Trypanosoma brucei gambiense",
        "Glycogens"
    ],
    "Authors": {
        "Richard O. Oduor": [
            "Opportunities for Partnering in Medicine, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom"
        ],
        "Kayode K. Ojo": [
            "Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, United States of America"
        ],
        "Gareth P. Williams": [
            "High Throughput Screening Center of Emphasis, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom"
        ],
        "Francois Bertelli": [
            "High Throughput Screening Center of Emphasis, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom"
        ],
        "James Mills": [
            "Worldwide Medicinal Chemistry, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom"
        ],
        "Louis Maes": [
            "Laboratory for Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, Belgium"
        ],
        "David C. Pryde": [
            "Worldwide Medicinal Chemistry, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom"
        ],
        "Tanya Parkinson": [
            "Opportunities for Partnering in Medicine, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom"
        ],
        "Wesley C. Van Voorhis": [
            "Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, United States of America"
        ],
        "Tod P. Holler": [
            "Opportunities for Partnering in Medicine, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom"
        ]
    }
}